ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
132.91
+2.56 (1.96%)
Feb 23, 2026, 4:00 PM EST - Market closed
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 67 employees as of September 30, 2025. The number of employees increased by 5 or 8.06% compared to the same quarter last year.
Employees
67
Change
5
Growth
8.06%
Revenue / Employee
$93,006
Profits / Employee
-$5,140,086
Market Cap
10.12B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 67 | 5 | 8.06% | 67 | 0 |
| Jun 30, 2025 | 69 | 7 | 11.29% | 69 | 0 |
| Mar 31, 2025 | 69 | 8 | 13.11% | 69 | 0 |
| Jun 30, 2024 | 62 | - | - | 62 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| BioMarin Pharmaceutical | 3,040 |
| Jazz Pharmaceuticals | 2,800 |
| Exelixis | 1,077 |
| Axsome Therapeutics | 816 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 673 |
| Madrigal Pharmaceuticals | 528 |
ABVX News
- 1 day ago - Abivax (ABVX) Highlights Promising Obefazimod Data at ECCO Congress - GuruFocus
- 2 days ago - Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 - GlobeNewsWire
- 6 days ago - Alger Mid Cap Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 13 days ago - Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - The Motley Fool
- 24 days ago - Better Long-Term Buy: This Emerging Player or the Industry Leader? - The Motley Fool
- 25 days ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 4 weeks ago - Eli Lilly (LLY) Denies Acquisition Talks with Abivax (ABVX) - GuruFocus
- 4 weeks ago - Abivax CEO responds to Lilly acquisition rumors - Seeking Alpha